2m 2m 2m 2m 2m 2m 2m
Haemonetics (HAE)
NYSE
$102.67-$0.02 (-0.02%)
Price as of Sep 11, 2026 7:30 PM EDT- $4.7BMarket Cap
- 96.72%1-Year Change
- Medical DevicesIndustry
Haemonetics (HAE)
$102.67-$0.02 (-0.02%)
HAE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $102.69 | ||
Change | +$1.63 (+1.61%) | ||
Open | $101.70 | ||
High | $102.89 | ||
Low | $100.53 | ||
Previous Close | $101.06 | ||
Volume | 458,308 | ||
30-Day Average Volume | 732,753 | ||
1-Week Change | -0.22% | ||
1-Month Change | 17.74% | ||
1-Year Change | 96.72% | ||
3-Year Change | 13.16% | ||
5-Year Change | 52.20% | ||
Fundamentals | |||
Shares Outstanding | 45.5M | ||
Total Assets | $2.4B | ||
Market Cap | $4.7B | ||
Enterprise Value | $5.6B | ||
Period: QTR TTM FY | |||
Revenue | $339.4M | ||
Net Income | $33.0M | ||
Free Cash Flow | $44.4M | ||
EBIT | $52.8M | ||
EBITDA | $79.9M | ||
Net Working Capital | $547.6M | ||
EPS | $0.72 | ||
Enterprise Value/EBITDA | 70 | ||
Enterprise Value/Revenue | 17 | ||
P/B | 6 | ||
P/E | 143 | ||
PEG | 1 | ||
Price/Free Cash Flow | 105 | ||
Price/Operating Cash Flow | 89 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 12/03/2012 | ||
Earnings & Revenue